Number of the day - 1041 Ion systems
Intuitive's Q1 numbers are out:
- "Worldwide procedures (da Vinci and Ion combined) grew approximately 17% compared with the first quarter of 2025. Da Vinci procedures grew approximately 16%, and Ion procedures grew approximately 39%.
- The Company placed 431 da Vinci surgical systems, compared with 367 in the first quarter of 2025. The first quarter 2026 da Vinci surgical system placements included 232 da Vinci 5 systems, compared with 147 in the first quarter of 2025. The Company placed 52 Ion endoluminal systems, compared with 49 in the first quarter of 2025.
- The Company grew its da Vinci surgical system installed base to 11,395 systems as of March 31, 2026, an increase of 12% compared with 10,189 as of March 31, 2025. The Company grew its Ion endoluminal system installed base to 1,041 systems as of March 31, 2026, an increase of 22% compared with 853 as of March 31, 2025.
- First quarter 2026 revenue of $2.77 billion increased 23%, compared with $2.25 billion in the first quarter of 2025.
- First quarter 2026 GAAP net income attributable to Intuitive Surgical, Inc. was $822 million, or $2.28 per diluted share, compared with $698 million, or $1.92 per diluted share, in the first quarter of 2025.
- First quarter 2026 non-GAAP* net income attributable to Intuitive Surgical, Inc. was $901 million, or $2.50 per diluted share, compared with $662 million, or $1.81 per diluted share, in the first quarter of 2025.
- The Company repurchased 2.3 million shares of its common stock for $1.1 billion in the first quarter of 2026."
Comments